JACE Pharma

Jace Pharmaceuticals is a specialty biotechnology company based in Birmingham, Alabama, focused on developing innovative therapies for respiratory and orphan diseases. The company's lead candidate, JACE-001, is an inhaled formulation of reduced glutathione designed to restore antioxidant levels in the lungs of patients with cystic fibrosis and other chronic pulmonary conditions. By leveraging expertise in drug formulation and delivery, Jace Pharmaceuticals aims to address significant unmet medical needs in the pulmonary space. The company has successfully completed Phase 2 clinical trials evaluating the safety and tolerability of its lead antioxidant therapy.